BeyondSpring Inc.
NASDAQ:BYSI · NASDAQ Capital Market
-$0.08 today
Vol 0.01M · Avg 0.02M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
24.8%
avg 39.8%
ROIC
-70.6%
avg -43.2%
ROA
-30.8%
avg -149.6%
Analysis
ROE is currently the strongest return metric at 24.8% versus its period average of 39.8%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Lan Huang | Co-Founder, Chairman & Chief Executive Officer | $664,660.00 | — | 55 | $11,514.00 | 0.03% |
June Lu | Chief Scientific Officer | $329,633.00 | — | 60 | $17,840.00 | 0.04% |
Joy Jia | VP of Finance | — | — | — | — | — |
Stephen Kilmer | Head of Investor Relations | — | — | — | — | — |
John Mao | Senior Vice President of Development | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
63
$2.02M
Net Sentiment
$2.02M
Net selling
Most Active
Decheng Capital China Life Sciences USD Fund III, L.P.
63 transactions
1–10 of 63
Analysis
Insiders reported 0 buys worth $0.00 and 63 sells worth $2.02M over the last 12 months. That adds up to net selling of $2.02M. Decheng Capital China Life Sciences USD Fund III, L.P. was the most active insider with 63 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | N/A | N/A1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Analysis will appear once historical growth or forward estimates are available for this company.
Competitors
Peer companies in the same sector
ALX Oncology Holdings Inc.
NASDAQ:ALXO
$212.61M
Unicycive Therapeutics, Inc.
NASDAQ:UNCY
$155.81M
Repare Therapeutics Inc.
RPTX
$114.24M
CAMP4 Therapeutics Corporation
NASDAQ:CAMP
$89.00M
Precision BioSciences, Inc.
NASDAQ:DTIL
$78.25M
MindWalk Holdings Corp.
NASDAQ:HYFT
$72.87M
Biomea Fusion, Inc.
NASDAQ:BMEA
$69.61M
Fractyl Health, Inc. Common Stock
NASDAQ:GUTS
$61.36M
aTyr Pharma, Inc.
ATYR
$43.18M
Quince Therapeutics, Inc.
QNCX
$5.20M
Who manages BYSI?
BeyondSpring Inc. (BYSI) lists 5 active executives. The top listed executive is June Lu, Chief Scientific Officer.
Are BYSI insiders buying or selling?
Recent insider activity shows net selling of $1.56M.
Explore More
Continue the stock analysis
Jump to another research area for this company.